CTI BioPharma
Why Robinhood?
You can watch CTI BioPharma and buy or sell other stocks, ETFs, and their options commission-free!About CTIC
CTI BioPharma Corp. engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis.
CTIC Key Statistics
Stock Snapshot
The current CTI BioPharma(CTIC) stock price is $9.09, with a market capitalization of 1.2B. The stock trades at a price-to-earnings (P/E) ratio of -15.78.
CTI BioPharma(CTIC) stock opened on 2026-10-26 at —. The price climbed to — and dipped to —.
The CTI BioPharma(CTIC)'s current trading volume is 0, compared to an average daily volume of 4.57M.
During the past year, CTI BioPharma(CTIC) stock moved between $4.01 at its lowest and $9.10 at its peak.
During the past year, CTI BioPharma(CTIC) stock moved between $4.01 at its lowest and $9.10 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.